Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)

SHE:000597 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,386	4,468	5,651	3,845	2,550	1,481
Cash & Short-Term Investments	3,386	4,468	5,651	3,845	2,550	1,481
Cash Growth	-41.81%	-20.93%	46.98%	50.76%	72.18%	-2.89%
Accounts Receivable	2,883	2,494	2,404	2,539	2,376	2,240
Other Receivables	225.63	192.51	191.25	195.93	392.21	421.06
Receivables	3,109	2,687	2,596	2,735	2,768	2,661
Inventory	1,311	1,324	1,364	1,220	1,247	1,253
Prepaid Expenses	-	0.63	1.17	2.86	16.64	11.66
Other Current Assets	135.66	166.73	171.05	127.39	216.56	145.66
Total Current Assets	7,941	8,646	9,783	7,931	6,799	5,553
Property, Plant & Equipment	3,947	4,064	4,477	4,852	5,226	5,489
Long-Term Investments	6.13	6.13	-	-	-	-
Goodwill	154.1	154.45	26.12	26.12	26.12	26.12
Other Intangible Assets	673.68	687.83	681.77	706.96	651.76	683.04
Long-Term Deferred Tax Assets	131.91	131.38	128.07	109.29	102.09	88.99
Long-Term Deferred Charges	744.21	742.05	143.47	122.36	302.5	262.94
Other Long-Term Assets	12.67	13.97	34.47	62.66	71.34	62.91
Total Assets	13,611	14,446	15,274	13,810	13,180	12,166
Accounts Payable	3,578	4,841	5,778	4,320	3,696	2,764
Accrued Expenses	2.62	853.78	744.07	701.69	561.28	396.14
Short-Term Debt	1,967	1,542	1,290	1,882	2,050	2,400
Current Portion of Long-Term Debt	58.83	-	688	42	200	-
Current Portion of Leases	-	20.23	23.52	17.58	20.21	-
Current Income Taxes Payable	54.97	46.22	55.58	104.58	28.27	39.62
Current Unearned Revenue	79.42	104.81	131.17	192.72	127.78	119.39
Other Current Liabilities	1,645	849.18	858.07	1,162	1,515	1,597
Total Current Liabilities	7,386	8,257	9,568	8,423	8,199	7,316
Long-Term Debt	78.4	-	150	238	200	200
Long-Term Leases	27.47	30.14	31.29	17.94	17.97	-
Long-Term Unearned Revenue	137.1	140.91	157.12	174.72	194.05	213.32
Long-Term Deferred Tax Liabilities	95.18	95.74	5.22	5.32	5.42	5.56
Other Long-Term Liabilities	281.86	352.83	202.8	238	273.2	308.4
Total Liabilities	8,006	8,877	10,115	9,097	8,889	8,043
Common Stock	1,429	1,429	1,429	1,434	1,348	1,351
Additional Paid-In Capital	2,490	2,490	2,468	2,375	2,146	2,188
Retained Earnings	1,497	1,461	1,194	978.13	646.81	558.57
Treasury Stock	-67.13	-67.13	-110.72	-234.78	-	-117.2
Comprehensive Income & Other	8.87	8.97	8.41	7.17	2.65	0.99
Total Common Equity	5,358	5,322	4,988	4,559	4,144	3,981
Minority Interest	247.08	248.03	170.47	153.95	146.54	141.6
Shareholders' Equity	5,605	5,570	5,159	4,713	4,290	4,122
Total Liabilities & Equity	13,611	14,446	15,274	13,810	13,180	12,166
Total Debt	2,132	1,593	2,183	2,198	2,488	2,600
Net Cash (Debt)	1,254	2,876	3,468	1,647	62.17	-1,119
Net Cash Growth	-63.16%	-17.08%	110.51%	2549.68%	-	-
Net Cash Per Share	0.89	2.03	2.42	1.18	0.04	-0.91
Filing Date Shares Outstanding	1,429	1,429	1,429	1,434	1,348	1,351
Total Common Shares Outstanding	1,429	1,429	1,429	1,434	1,348	1,351
Working Capital	554.88	389.56	214.57	-492.6	-1,399	-1,763
Book Value Per Share	3.75	3.72	3.49	3.18	3.07	2.95
Tangible Book Value	4,530	4,479	4,280	3,826	3,466	3,271
Tangible Book Value Per Share	3.17	3.13	3.00	2.67	2.57	2.42
Buildings	-	3,123	3,101	3,011	2,965	2,791
Machinery	-	5,177	5,047	4,808	4,606	4,627
Construction In Progress	-	155.48	198.87	421.64	678.41	733.22

Updated Oct 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.